Related Articles
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: A feasible and effective salvage treatment for lymphoid malignancies
Upfront high‑dose chemotherapy combined with autologous stem cell transplantation: Potential survival benefit for patients with high‑risk diffuse large B‑cell lymphoma
Multicyclic dose-intensive chemotherapy with circulating progenitor cell support for high-risk primary breast cancer.
Autologous bone marrow transplantation as consolidation therapy in newly diagnosed non-Hodgkin's lymphoma: long-term outcome.
FEC (FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE) PLUS GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF) IN ADVANCED OR INFLAMMATORY BREAST-CANCER - A DOSE-FINDING STUDY